Kedar Upadhye Appointed as CFO of Biocon Biologics

Kedar Upadhye was appointed as Chief Financial Officer (CFO) of Biocon Biologics Limited, a subsidiary of Biocon Limited, with effect from October 31, 2023. He replaced MB Chinappa, who has moved to a strategic finance role within the Biocon Group. Chinappa has been the CFO of Biocon Biologics since January 2020 and has played a significant role in shaping the company’s business strategy for growth.

Kedar Upadhye has more than 23 years of experience in various senior leadership roles in corporate finance, strategy, and other areas with companies like Cipla, Dr. Reddy’s, PepsiCo, and Thermax. Before joining Biocon Biologics, he was the CFO at ReNew Energy and the Global CFO at Cipla.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: